40. 高安動脈炎 Takayasu arteritis Clinical trials / Disease details


臨床試験数 : 24 薬物数 : 40 - (DrugBank : 18) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 110

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04882072
(ClinicalTrials.gov)
September 15, 202110/5/2021A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Ustekinumab in Participants With Takayasu ArteritisTakayasu ArteritisDrug: Ustekinumab;Other: Placebo;Drug: Glucorticoid Taper RegimenJanssen Pharmaceutical K.K.NULLActive, not recruiting15 Years75 YearsAll14Phase 3Japan